(Q48687180)

14 February 2018

reason for preferred rank

title

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats (English)

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

5 December 2022

The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834964

5 December 2022

0 references

0 references

W. Löscher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834964

5 December 2022

R. Annies

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834964

5 December 2022

D. Hönack

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834964

5 December 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

14 February 2018

22 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1834964

full work available at URL

5 December 2022

https://api.elsevier.com/content/article/PII:030439409190258U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

https://api.elsevier.com/content/article/PII:030439409190258U?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

5 December 2022

1 reference

14 February 2018

volume

128

1 reference

14 February 2018

page(s)

191-194

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

5 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Changes in catecholamine content in discrete brain nuclei during the estrous cycle of the rat

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Handling habituation and chlordiazepoxide have different effects on GABA and 5-HT function in the frontal cortex and hippocampus

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

NMDA antagonists interact with 5-HT-stimulated phosphatidylinositol metabolism and impair passive avoidance retention in the rat.

5 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

5 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Homovanillic acid levels in rat striatum during the oestrous cycle

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

5 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Development of a synaptosomal model to determine drug-induced in vivo changes in GABA-levels of nerve endings in 11 brain regions of the rat.

5 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Serotonergic involvement in phencyclidine-induced behaviors

5 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.

5 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors

5 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Concentration of Norepinephrine in the Hypothalamus of the Rat in Relation to the Estrous Cycle

5 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

5 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

5 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

5 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0304-3940(91)90258-U

5 December 2022

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018